Try our Advanced Search for more refined results
Searching dockets in Urovant Sciences Ltd x
Alert me of new activity
All Case Activity Alerts Include: Answers, Appeals, Complaints, Motions, Orders, Trial Notes
Patent - Abbreviated New Drug Application(ANDA) | Delaware
Notice of Service
NOTICE OF SERVICE of Plaintiffs' Disclosure of Claim Terms for Construction filed by Sumitomo Pharma America, Inc., Sumitomo Pharma Co., Ltd., Urovant Sciences GmbH.(Ying, Jennifer)
SO ORDERED
SO ORDERED, re 57 STIPULATION TO EXTEND TIME the deadline for the substantial completion of document production to July 10, 2026 filed by Hetero Labs Limited, Hetero USA Inc., Apotex Inc., Accord Healthcare Inc., Apotex Corp., Camber Pharmaceuticals, Inc., Annora Pharma Private Limited. Signed by Judge Gregory B. Williams on 6/15/2026. (lnb)
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login
Email (NOTE: Free email domains not supported)
First Name
Last Name
Job Title
PLEASE NOTE: A verification email will be sent to your address before you can access your trial.
Password (at least 8 characters required)
Confirm Password
Law360 may contact you in your professional capacity with information about our other products, services and events that we believe may be of interest.You’ll be able to update your communication preferences via the unsubscribe link provided within our communications.We take your privacy seriously. Please see our Privacy Policy.